A Phase 2, Randomized, Placebo-Controlled Study of Bermekimab in Moderate-to-Severe Hidradenitis Suppurativa
- PMID: 40865678
- DOI: 10.1016/j.jid.2025.07.032
A Phase 2, Randomized, Placebo-Controlled Study of Bermekimab in Moderate-to-Severe Hidradenitis Suppurativa
Keywords: Bermekimab; Efficacy; Hidradenitis Suppurativa Clinical Response; Hidradenitis suppurativa; Safety.
LinkOut - more resources
Full Text Sources
